643 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The Company may, in some cases, use terms
8-K
EX-10.2
7uiwyqv fn
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-2.1
4i8lws98976rzoj
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
hvk1q6 ibh
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
61zr7rthi5tau2y
31 Jan 24
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
8:00am
8-K
EX-10.1
csswde ufj
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
EX-99.1
0swj 8s91hc
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
8-K
EX-1.1
0z4ei
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
gke2vu kq
9 Nov 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
jbcu1a 3wljsltcvu
7 Aug 23
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
4:02pm
8-K
EX-99.1
xk0f7m yfdpa37vttr
15 May 23
Windtree Therapeutics Reports First Quarter 2023 Financial Results and Provides Key Business Updates
4:24pm